<DOC>
	<DOC>NCT00480194</DOC>
	<brief_summary>The objectives of the study are to obtain knowledge about the safety in use, the patients' general impression of the treatment and the pattern of use of ZyComb® in an over-the-counter (OTC) setting.</brief_summary>
	<brief_title>Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM)</brief_title>
	<detailed_description />
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<mesh_term>Xylometazoline</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>For inclusion the patient must buy ZyComb® nasal spray with the intention to start using it either the same or the next day.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>